Telmisartan, ramipril, or both in patients at high risk for vascular events. - Yusuf,S.; Teo,KK.; Pogue,J.; Dyal,L.; Copland,I.; Schumacher,H.; Dagenais,G.; Sleight,P.; Anderson,C. (N Engl J Med, 2008)